Abstract
The Multicenter Unsustained Tachycardia Trial (MUSTT) findings have yet to be published. However, as a result of presentation of the preliminary results at two major cardiology meetings, the publication is much anticipated. Since it is unpublished, its true clinical impact has yet to be determined. However, based on the response to similar important trials in arrhythmia management, we can make reasonable projections of the potential clinical relevance of this trial.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, Simson MB, DiCarlo L, Echt DS, Packer D, Greer GS, Talajic M, the MUSTT Investigators (1993) Prevention of sudden death in patients with coronary artery disease: the multicenter unsustained tachycardia trial (MUSTT). Prog Cardiovasc Dis 6:215–226
MADIT Executive Committee (1991) Multicenter automatic defibrillator implantation trial (MADIT): design and clinical protocol. PACE 14(II):920–927
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, for the Multicenter Automatic Defìbriïlator Implantation Trial (MADIT) Investigators (1996) Improved survival with an implanted derìbrülator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940
Higgins SL (1999) Impact of the Multicenter Automatic Defibrillator Implantation Trial (MADIT) on ICD indication trends: a two-year perspective. Am J Cardiol 83:79D–82D
Higgins SL, Klein H, Nisam S (1997) Which device should “MADIT protocol” patients receive? Am J Cardiol 79:31–35
Higgins SL, Daubert JL, Akhtar M (1997) Who are the MADIT patients? Am J Cardiol 79(5B):42–46F
Higgins SL, Voshage-Stahl L (1997) What have we learned from the US experience on the prophylactic use of ICDs following MADIT? In: Raviele A (ed) Cardiac Arrhythmias. Springer-Verlag, Milan, pp 270–275
Higgins S (1997) Will management of atrial arrhythmias be important in MADIT patients? In: Capucci A (ed) Atrial fibrillation, evolving concepts and new therapeutic strategies. Bologna
Nisam S (1997) Do MADIT results apply only to “MADIT Patients”? Am J Cardiol 79(6A):27–30
National Heart, Lung and Blood Institutes Communications (1997) NHLBI stops arrhythmia study-implantable cardiac defibrillators reduce deaths. NIH press release, April 14
Bocker D, Block M, Borggrefe M, Breithardt M (1997) Evidence-based cardiology: defibrillators are superior to anti-arrhythmic drugs in the treatment of ventricular tachyarrhythmias. Eur Heart J 18:26–30
Cannom DS (1998) A review of the implantable cardioverter defibrillator trials. Curr Opin Cardiol 13:3–8
Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, Zou KH, Moss AJ (1988) The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT: Multicenter Automatic Defibrillator Implantation Trial. Circulation 97:2129–2135
Viskins S, Kitzis I, Lev E, Zak Z, Heller K, Villa Y, Zajanas A, Laniado S, Beihassen B (1995) Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 25:1327–1332
Garg R, Yusuf S, Collaborative Group on ACE Inhibitor Trials (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 18:1450–1456
The AVID investigators (1997) A comparison of anti-arrhythmic drug therapy with implantable defìbrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 337:1576–1583
Cairns JA, Connolly SJ, Roberts R, Gent M (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 49:675–682
Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P (1997) Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 49:667–674
Maloney JD (1989) Consequences of the Cardiac Arrhythmia Suppression Trial: calamity or clarity? Clev Clin J Med 56:649–653
Friedman P, Stevenson W (1996) Unsustained ventricular tachycardia-to treat or not to treat. N Engl J Med 335:1984–1985 (editorial)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Italia
About this paper
Cite this paper
Higgins, S.L. (2000). What Are the Clinical Implications of MUSTT?. In: Raviele, A. (eds) Cardiac Arrhythmias 1999. Springer, Milano. https://doi.org/10.1007/978-88-470-2139-6_54
Download citation
DOI: https://doi.org/10.1007/978-88-470-2139-6_54
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2178-5
Online ISBN: 978-88-470-2139-6
eBook Packages: Springer Book Archive